Benzinga Strategies
Rodman and Renshaw's Benjamin on the DNDN earnings debacle
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:14:07
- More information
Informações:
Synopsis
Rodman and Renshaw senior biotech analyst Dr. Reni Benjamin discusses the causes behind the more than 60% wipeout in Dendreon's market value after their earnings report and how he is tweaking his models going forward.
